Full Bio Michael Alt has been appointed to the Court in June 2023. His technical focus is in the following areas: pharma, biotech, chemistry, medical devices. Professional Experience in Intellectual Property August 2024 - present: patent attorney in single practice May 2006 - July 2024: German and European patent and trademark attorney at Bird & Bird LLP (last position: partner) April 2001 – April 2006: German and European patent and trademark attorney at the vaccine-focused biopharmaceutical company Bavarian Nordic GmbH, Martinsried November 2001: Entry on the list of professional representatives before the European patent office October 2001: Entry on the list of professional representatives before the Office for harmonization in the internal market September 2001: Entry on the list of German patent attorneys February 1997 – January 2001: Patent attorney trainee Studies of law for patent attorneys at the Fernuniversität Hagen Professional Experience in Science May 1993 – January 1997: Max-Planck-Institute for Biochemistry, Department of Virus Research; research focus: hepatitis C virus therapies, hepatitis B virus, antisense oligonucleotides and ribozymes, gene therapy based on AAV vectors. Education November 1988 – December 1992: Ph.D. thesis in molecular virus research at the Institute for Clinical and Molecular Virus Research, University of Erlangen-Nürnberg, Germany. November 1982 – October 1988: Studies of biology with a focus on biochemistry, virology, organic chemistry and zoology at the University of Erlangen-Nürnberg; research at the Institut de Biologie Moléculaire et Cellulaire du CNRS, Strasbourg, France. Diploma in biology Name of any other employer of the judge or administration/court the judge is serving for N/A
Full Bio Michael Alt has been appointed to the Court in June 2023. His technical focus is in the following areas: pharma, biotech, chemistry, medical devices. Professional Experience in Intellectual Property August 2024 - present: patent attorney in single practice May 2006 - July 2024: German and European patent and trademark attorney at Bird & Bird LLP (last position: partner) April 2001 – April 2006: German and European patent and trademark attorney at the vaccine-focused biopharmaceutical company Bavarian Nordic GmbH, Martinsried November 2001: Entry on the list of professional representatives before the European patent office October 2001: Entry on the list of professional representatives before the Office for harmonization in the internal market September 2001: Entry on the list of German patent attorneys February 1997 – January 2001: Patent attorney trainee Studies of law for patent attorneys at the Fernuniversität Hagen Professional Experience in Science May 1993 – January 1997: Max-Planck-Institute for Biochemistry, Department of Virus Research; research focus: hepatitis C virus therapies, hepatitis B virus, antisense oligonucleotides and ribozymes, gene therapy based on AAV vectors. Education November 1988 – December 1992: Ph.D. thesis in molecular virus research at the Institute for Clinical and Molecular Virus Research, University of Erlangen-Nürnberg, Germany. November 1982 – October 1988: Studies of biology with a focus on biochemistry, virology, organic chemistry and zoology at the University of Erlangen-Nürnberg; research at the Institut de Biologie Moléculaire et Cellulaire du CNRS, Strasbourg, France. Diploma in biology Name of any other employer of the judge or administration/court the judge is serving for N/A